Biostatistics Market Analysis and Reports | USA Conference Series

Market Analysis - Biostatistics 2017

According to Bcc report, it is estimated that the global bioinformatics market was valued at nearly $2.8 billion in 2011, nearly $3.2 billion in 2012, and is forecast to grow to nearly $7.5 billion by 2017 after increasing at a compound annual growth rate (CAGR) of 18.7%. The bioinformatics market is projected to reach USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing at a CAGR of 21.1% during the forecast period according to MarketsandMarkets report. As per the Allied Market Research, the global Bioinformatics market was valued at $3.4 billion in 2013, and it is expected to reach $12.8 billion by 2020. The market is expected to grow at a CAGR of 21.2% during 2014-2020. Major contributing factors for this growth are increasing application of drug discovery and development using bioinformatics tools, which proves to be cost and time efficient for the pharmaceutical companies. However, the bioinformatics platforms segment is expected to grow at the highest CAGR during the forecast period; high growth in this segment can be attributed to the advantages of bioinformatics platforms, such as reduction in overall time for processing data, phylogenetic analysis, and identification of sequence similarity. By 2020, knowledge management tools are expected to take over platform market and would emerge as the highest revenue generating segment in the overall bioinformatics technology and service market. European market will grow from nearly $1.1 billion in 2015 to $1.7 billion in 2019 at a CAGR of 12.0% for the period 2014-2019.

Why to attend?

With members from around the world focused on learning about Biometrics & biostatistics, this is your single best opportunity to reach the largest assemblage of participants from the statistical community. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Biometrics & Biostatistics fields are hallmarks of this conference.

Why Atlanta? ? ?

Atlanta is the capital of and the most populous city in the U.S. state of Georgia, with an estimated 2015 population of 463,878. Atlanta is the cultural and economic centre of the Atlanta metropolitan area, home to 5,522,942 people and the ninth largest metropolitan area in the United States. Atlanta is the county seat of Fulton County, and a small portion of the city extends eastward into DeKalb County.

Atlanta was established in 1837 at the intersection of two railroad lines, and the city rose from the ashes of the American Civil War to become a national centre of commerce. In the decades following the Civil Rights Movement, during which the city earned a reputation as "too busy to hate" for the relatively progressive views of some of its citizens and leaders compared to other cities in the Deep South Atlanta attained international prominence. Atlanta is the primary transportation hub of the Southeastern United States, via highway, railroad, and air, with Hartsfield–Jackson Atlanta International Airport being the world's busiest airport since 1998.

Atlanta is an "alpha-" or "world city", exerting a significant impact upon commerce, finance, research, technology, education, media, art, and entertainment. It ranks 36th among world cities and 8th in the nation with a gross domestic product of $270 billion. Atlanta's economy is considered diverse, with dominant sectors including logistics, professional and business services, media operations, and information technology. Topographically, Atlanta is marked by rolling hills and dense tree coverage. Revitalization of Atlanta's neighborhoods, initially spurred by the 1996 Olympics in Atlanta, has intensified in the 21st century, altering the city's demographics, politics, and culture

Major Biostatistics and Bioinformatics Related Associations around the Globe:

International Society for Clinical Biostatistics
Society for Clinical Trials
The Canadian Society for epidemiology and Biostatistics
Statistical Society of Australia
Statistical Modelling Society
Royal Statistical Society
SSC Statistical Society of Canada
Società Italiana di Bioinformatica
Swiss Institute of Bioinformatics
International Chinese Statistical Association
International Society for Computational Biology - ISCB
PSI Statisticians in the Pharmaceutical Industry
American Statistical Association

Target Audience:
Artificial Intelligence Experts
Biostatisticians/Bioinformaticians/data scientists
Directors/Managers of Biostatistics/bioinformatics related organization
Bioinformatics professionals and researchers
Software developers
Security devices manufacturers
Statistical and biometrics associations
Societies
Universities and Colleges
Business Entrepreneurs
Researchers

Academia: - 70 percent

Industry: - 30 percent